Analyst firms · Morgan Stanley · CNC

Morgan Stanley CNC price target and rating history

Centene Corporation (CNC) · Health Care

Morgan Stanley rates Centene Corporation (CNC) Equal-Weight with a $33 price target, as of its latest action on Jul 10, 2025. It has published 7 rating actions on CNC since August 2021, including 0 upgrades and 2 downgrades. Across 6 firms with a CNC price target in the last 12 months, the median target is $65.

Current rating
Equal-Weight
Price target
$33
Median target, all firms
$65
Actions on CNC
7

Morgan Stanley price target on CNC

$109$71$3320222023202420252026
Morgan Stanley price target on CNC, each point a stated target, August 2021 to July 2025.

Every Morgan Stanley rating on CNC

How other firms rate CNC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchBuy$80Aug 11, 2026
RBC Capital MarketsSector Perform$70Jun 23, 2026
Deutsche BankBuy$80May 20, 2026
Cantor FitzgeraldOverweight$60Apr 29, 2026
BofA SecuritiesBuy$60Apr 29, 2026
BarclaysOverweight$54Jan 5, 2026

Questions about Morgan Stanley and CNC

What is Morgan Stanley's price target for CNC?
Morgan Stanley's latest stated price target for Centene Corporation (CNC) is $33, from its action on Jul 10, 2025.
What is Morgan Stanley's rating on CNC?
Morgan Stanley rates CNC Equal-Weight, a neutral rating, as of Jul 10, 2025.
When did Morgan Stanley last change its view on CNC?
On Jul 10, 2025, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $33.
How does Morgan Stanley's CNC target compare with other analysts?
Across 6 firms with a CNC price target in the last 12 months, the median target is $65.

More CNC rating histories

All Morgan Stanley ratingsCNC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.